SCHEMBL7595176

SCHEMBL7595176

CCSC(=N)Nc1ccc(CCNCc2cccc(Cl)c2)cc1.CS(=O)(=O)O.CS(=O)(=O)O

nearest known ligand 0.51

Known targets — ChEMBL curated mechanism

ABL1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB2AGTR1BCL2BCL2A1BCL2L1BCL2L10BCL2L2BCRBRAFCHRM1CHRNA10CHRNA9DRD1DRD2DRD3DRD4DRD5EGFRF2FLT1FLT4GCKGHSRGNRHRGRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BHTR1AHTR1BHTR1DHTR2AHTR2CHTR3AIDH2KDRKITMAOBMCL1MTTPPP4HBPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PIKFYVEROCK1ROCK2SLC18A2SLC6A2SLC6A3SLC6A4TACR1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8gyrAgyrBparCparEpol

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.51
CYP3A4 P08684 2/20 0.51
CYP2D6 P10635 2/20 0.51
CYP2C19 P33261 2/20 0.51
SLC2A1 P11166 2/20 0.48
HDAC1 Q13547 1/20 0.47
CNR1 P21554 1/20 0.46
NOS3 P29474 2/20 0.43
CHRM2 P08172 1/20 0.43
NOS1 P29475 1/20 0.43
NOS2 P35228 1/20 0.43
MAPT P10636 4/20 0.42
ADRB3 P13945 1/20 0.42
F7 P08709 1/20 0.41
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
LMNA P02545 2/20 0.41
CYP2C9 P11712 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7597938 0.96 CYP1A2 (0.55) CYP1A2CYP3A4CYP2D6CYP2C19SLC2A1
SCHEMBL7595893 0.79 CYP1A2 (0.60) CYP1A2CYP3A4CYP2D6CYP2C19SLC2A1
SCHEMBL9037983 0.77 CYP1A2 (0.56) CYP1A2CYP3A4CYP2D6CYP2C19SLC2A1
Hydrochloric Acid SCHEMBL6956565 0.76 CYP1A2 (0.58) CYP1A2CYP3A4CYP2D6CYP2C19SLC2A1
SCHEMBL7599284 0.75 CYP1A2 (0.60) CYP1A2CYP3A4CYP2D6CYP2C19SLC2A1
SCHEMBL29521416 0.75 HDAC1 (0.64) CYP1A2CYP3A4CYP2D6CYP2C19SLC2A1
SCHEMBL21114827 0.75 HDAC1 (0.64) CYP1A2CYP3A4CYP2D6CYP2C19SLC2A1
SCHEMBL579570 0.74 CYP1A2 (0.53) CYP1A2CYP3A4CYP2D6CYP2C19SLC2A1
SCHEMBL122445 0.73 NOS3 (0.64) CYP1A2CYP3A4CYP2D6CYP2C19SLC2A1
SCHEMBL29558856 0.73 NOS3 (0.64) CYP1A2CYP3A4CYP2D6CYP2C19SLC2A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0782567-B2 ISOTHIOUREA DERIVATIVES AS NO SYNTHASE INHIBITORS ASTRA AB (SE) 2002-12-11 EP disclosed
EP-0782567-B1 ISOTHIOUREA DERIVATIVES AS NO SYNTHASE INHIBITORS ASTRA AB (SE) 1999-06-30 EP disclosed
US-5721247-A Isothiourea derivatives useful in therapy ASTRA AKTIEBOLAG (SE) 1998-02-24 US disclosed
EP-0782567-A1 ISOTHIOUREA DERIVATIVES AS NO SYNTHASE INHIBITORS Astra Aktiebolag (SE) 1997-07-09 EP disclosed
WO-1996009286-A1 ISOTHIOUREA DERIVATIVES AS NO SYNTHASE INHIBITORS ASTRA AKTIEBOLAG (SE) 1996-03-28 WO disclosed